An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra; Ana Laura Añé-Kourí; Naivy Sánchez; Lázaro Manuel Filgueira; J. R. Betancourt; Carlos Herrera; Leniel Manso; Elibet Chávez; Armando Caballero; Carlos Hidalgo; Geydi Lorenzo; Meylán Cepeda; Carmen Valenzuela; Mayra Ramos; Kalet León; Zaima Mazorra; Tania Crombet

doi:10.1186/s12979-020-00207-8

Preprint2020

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio L. Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, C. Hidalgo, Geydi Lorenzo, Meylán Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

Preprint2020

An Anti-CD6 Monoclonal Antibody (Itolizumab) Reduces Circulating IL-6 in Severe Covid-19 Elderly Patients

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio L. Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, C. Hidalgo, Geydi Lorenzo, Meylán Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

Preprint2020

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio L. Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, C. Hidalgo, Geydi Lorenzo, Meylán Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet

Preprint2020

Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19

Yayquier Díaz, Mayra Ramos, Yordanis Martín, Néstor Antonio Calderón, William Santiago, Orlando Viñet, O Yulieski La, J.L. Beato Pérez, Augusto Oyarzábal, Yoan Pérez, Geidy Lorenzo, Meylán Cepeda, Danay Saavedra, Zaima Mazorra, Daymys Estévez, Patricia Lorenzo-Luaces, Carmen Valenzuela, Armando Caballero, Kalet León, Tania Crombet, Carlos Jorge Hidalgo

Article2020

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

Yayquier Díaz, Mayra Ramos, Yordanis Martín, Néstor Antonio Calderón, William Santiago, Orlando Viñet, Yulieski La O, Jorge Pérez Augusto Oyarzábal, Yoan Pérez, Geidy Lorenzo, Meylán Cepeda, Danay Saavedra, Zaima Mazorra, Daymys Estévez, Patricia Lorenzo-Luaces, Carmen Valenzuela, Armando Caballero, Kalet León, Tania Crombet, Carlos Jorge Hidalgo

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Discussion(0)

Related publications

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

An Anti-CD6 Monoclonal Antibody (Itolizumab) Reduces Circulating IL-6 in Severe Covid-19 Elderly Patients

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19